Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
€ 63,98 ↑2.18 (3.53%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership23,795 shares
Latest Disclosed Value $ 959,176
Captrust Financial Advisors reports 152.55% increase in ownership of HTD / Corcept Therapeutics Incorporated

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 23,795 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $820,690 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 9,422 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 152.55% during the quarter. The current value of the position is $1,522,404 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 23,795 14,373 152.55 959 193.27 0.0017
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 9,422 -1,426 -13.15 328 -63.71 0.0006
2025-11-19 2025-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 10,848 2,717 33.42 902 51.17 0.0018
2025-08-15 2025-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 8,131 -1,001 -10.96 597 -42.86 0.0013
2025-05-15 2025-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 9,132 -104,856 -91.99 1,043 -81.84 0.0026
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 113,988 10,248 9.88 5,744 19.62 0.0164
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 103,740 -19,255 -15.66 4,801 20.15 0.0142
2024-08-15 2024-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 122,995 -6,676 -5.15 3,996 22.35 0.0129
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 129,671 -12,401 -8.73 3,266 -29.22 0.0120
2024-02-14 2023-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 142,072 -908 -0.64 4,614 18.46 0.0159
2023-11-15 2023-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 142,980 -85,187 -37.34 3,896 -23.27 0.0149
2023-08-15 2023-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 228,167 621 0.27 5,077 3.00 0.0200
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 227,546 208,844 1,116.69 4,929 1,200.26 0.0217
2023-02-15 2022-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 18,702 147 0.79 380 -20.38 0.0019
2022-11-16 2022-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 18,555 10,923 143.12 476 162.98 0.0028
2022-08-23 2022-06-30 13F/A-1 CORCEPT THERAPEUTICS INC COM Common Stock 218352102 7,632 827 12.15 181 18.30 0.0012
2022-08-16 2022-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 14,503 7,698 345 0.0025
2022-05-16 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 6,805 3,181 87.78 153 112.50 0.0010
2022-02-14 2021-12-31 13F CORCEPT THERAPEUTICS INC COM Common Stock 218352102 3,624 256 7.60 72 9.09 0.0005
2021-11-16 2021-09-30 13F CORCEPT THERAPEUTICS INC COM Common Stock 218352102 3,368 37 1.11 66 -9.59 0.0005
2021-08-16 2021-06-30 13F CORCEPT THERAPEUTICS INC COM Common Stock 218352102 3,331 -644 -16.20 73 -23.16 0.0007
2021-05-17 2021-03-31 13F CORCEPT THERAPEUTICS INC COM Common Stock 218352102 3,975 3,755 1,706.82 95 1,483.33 0.0010
2021-02-16 2020-12-31 13F CORCEPT THERAPEUTICS INC COM Common Stock 218352102 220 100 83.33 6 200.00 0.0001
2020-11-17 2020-09-30 13F CORCEPT THERAPEUTICS INC COM Common Stock 218352102 120 120 2 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.